Endothelial Dysfunction Markers Correlate with the Time Since Completion of Tuberculosis Treatment and the Number of Previous Tuberculosis Episodes
Authors:
- Chrisstoffel JumaarCJChrisstoffel Jumaar
- Steve JacobsSJSteve Jacobs
- Carmen PayneCPCarmen Payne
- Olakunle SanniOSOlakunle Sanni
- Elize LouwELElize Louw
- Nicola BainesNBNicola Baines
- David MareeDMDavid Maree
- Benjamin BothaBBBenjamin Botha
- Merga Belina FeyasaMFMerga Belina Feyasa
- Hans StrijdomHSHans Strijdom
- Brian AllwoodBABrian Allwood
- Gerald J. MaarmanGerald J. Maarman
Open Access
- 28 February 2025
- journal article
- research article
- Published by MDPI AG in Infectious Disease Reports
- Vol. 17 (2) , 21
Abstract
Background: Despite “successful” treatment, some lung tuberculosis (TB) patients develop long-term lung impairments that includes damage to the parenchyma and reduced function, which may predispose them to diseases like pulmonary hypertension. However, this is not well understood. Therefore, we investigated whether previous or current TB patients would display elevated biomarkers of endothelial dysfunction and vascular remodeling. Methods: We performed assays for ADMA, VCAM-1, VEGF, angiopoietin-1, TBARS, NT-pro-BNP, and cardiac troponin-I. We further stratified the patients based on 1, 2, 3, and >3 previous TB episodes, and 1–5 yrs, 5–10 yrs, 10–15 yrs and >15 yrs after the last TB treatment completion. We also assessed correlations between the biomarkers and the number of previous TB episodes or the time since the completion of the last TB treatment. Results: ADMA was 70 times higher, VEGF was 2000 times higher and angiopoietin-1 was 6500 times higher than the normal range. NT-pro-BNP and cardiac troponin-I were undetected, and TBARS levels were low. There was a positive linear relationship between the number of previous TB episodes and angiopoietin-1, and between VEGF and the number of previous TB episodes. ADMA, VCAM-1 and TBARS exhibited a weak and negative linear association with the number of previous TB episodes. A negligible negative linear association was observed between the time since the completion of the last TB treatment and angiopoietin-1, VEGF and ADMA. Conclusions: Therefore, having >1 previous TB episode, despite the successful completion of TB treatment, associates with an increased risk of endothelial dysfunction/angiogenesis or vascular remodeling.Keywords
Funding Information
- NIHR Global Health Research Unit on Lung Health and Tuberculosis in Africa at LSTM (IMPALA) (16/136/35, RP10090, 35671, K2443)
- South African Medical Research Council (16/136/35, RP10090, 35671, K2443)
- National Research Foundation of South Africa (16/136/35, RP10090, 35671, K2443)
- The Harry Crossley Foundation (16/136/35, RP10090, 35671, K2443)
- Faculty of Health Sciences, Stellenbosch University (16/136/35, RP10090, 35671, K2443)
This publication has 25 references indexed in Scilit:
- Vascular cell-adhesion molecule 1 (VCAM-1) regulates JunB-mediated IL-8/CXCL1 expression and pathological neovascularizationCommunications Biology, 2023
- Plasma asymmetric dimethylarginine is associated with vulnerable plaque and long-term outcomes in stable coronary artery diseaseScientific Reports, 2023
- Post tuberculosis lung disease and tuberculosis sequelae: A narrative reviewIndian Journal of Tuberculosis, 2023
- The prevalence of pulmonary hypertension after successful tuberculosis treatment in a community sample of adult patientsPulmonary Circulation, 2023
- Alterations in intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) in human endothelial cellsTissue and Cell, 2018
- Assessment of Antioxidant Potential of Dietary Components2018
- Biological markers of oxidative stress: Applications to cardiovascular research and practiceRedox Biology, 2013
- ADMA and SDMA levels in healthy men exposed to tobacco smokeAtherosclerosis, 2009
- Where is VEGF in the body? A meta-analysis of VEGF distribution in cancerBritish Journal of Cancer, 2007
- Improved analysis of malondialdehyde in human body fluidsFree Radical Biology and Medicine, 1996